Phosphate Binding Therapy to Lower Serum Fibroblast-Growth-Factor-23 Concentrations in Chronic Kidney Disease: Rationale and Study Design of the Sevelamer on FGF23 Trial (SoFT)

Aaltje Y. Adema; Maarten A. de Jong; Martin H. de Borst; Pieter M. ter Wee; Marc G. Vervloet

doi:10.1159/000448184

Phosphate Binding Therapy to Lower Serum Fibroblast-Growth-Factor-23 Concentrations in Chronic Kidney Disease: Rationale and Study Design of the Sevelamer on FGF23 Trial (SoFT)

Aaltje Y. Adema, Maarten A. de Jong, Martin H. de Borst, Pieter M. ter Wee, Marc G. Vervloet

Affiliatie VU

University Medical Center Groningen

Research output: Contribution to journal › Article › Professional

6 Citations (Scopus)

Original language	English
Pages (from-to)	215-220
Journal	Nephron
Volume	134
Issue number	4
DOIs	https://doi.org/10.1159/000448184
Publication status	Published - 2016

Keywords

Fibroblast growth factor-23
Sevelamer
Chronic kidney disease
Phosphate binding therapy
Sevelamer on FGF23 trial
SoFT

Access to Document

10.1159/000448184

Cite this

@article{9108084c17444fe6a1b84de59248b32c,

title = "Phosphate Binding Therapy to Lower Serum Fibroblast-Growth-Factor-23 Concentrations in Chronic Kidney Disease: Rationale and Study Design of the Sevelamer on FGF23 Trial (SoFT)",

keywords = "Fibroblast growth factor-23, Sevelamer, Chronic kidney disease, Phosphate binding therapy, Sevelamer on FGF23 trial, SoFT",

author = "Adema, {Aaltje Y.} and {de Jong}, {Maarten A.} and {de Borst}, {Martin H.} and {ter Wee}, {Pieter M.} and Vervloet, {Marc G.}",

year = "2016",

doi = "10.1159/000448184",

language = "English",

volume = "134",

pages = "215--220",

journal = "Nephron",

issn = "1660-8151",

publisher = "S. Karger AG",

number = "4",

}

TY - JOUR

T1 - Phosphate Binding Therapy to Lower Serum Fibroblast-Growth-Factor-23 Concentrations in Chronic Kidney Disease: Rationale and Study Design of the Sevelamer on FGF23 Trial (SoFT)

AU - Adema, Aaltje Y.

AU - de Jong, Maarten A.

AU - de Borst, Martin H.

AU - ter Wee, Pieter M.

AU - Vervloet, Marc G.

PY - 2016

Y1 - 2016

KW - Fibroblast growth factor-23

KW - Sevelamer

KW - Chronic kidney disease

KW - Phosphate binding therapy

KW - Sevelamer on FGF23 trial

KW - SoFT

U2 - 10.1159/000448184

DO - 10.1159/000448184

M3 - Article

C2 - 27442253

SN - 1660-8151

VL - 134

SP - 215

EP - 220

JO - Nephron

JF - Nephron

IS - 4

ER -